Rituximab not superior to conventional strategy for eosinophilic granulomatosis with polyangiitis
For patients with eosinophilic granulomatosis with polyangiitis (EGPA), rituximab is not superior to the conventional remission induction strategy, according to a study published online July 29 in the Annals of Internal Medicine.
Aug 1, 2025
0
13









